H.R. 19
Referred to CommitteeLower Costs, More Cures Act of 2019
Latest Action
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
12/19/2019 • House
Summary
Lower Costs, More Cures Act of 2019
This bill establishes and modifies several requirements to address prescription drug prices under Medicare, Medicaid, and other programs.
The bill generally
- limits payment amounts for drugs and biologics under Medicare medical services,
- reduces cost-sharing under the Medicare prescription drug benefit,
- modifies certain authorities and requirements under the Medicaid Drug Rebate Program,
- revises provisions relating to regulatory approval and commercial availability of generics and biosimilars, and
- establishes several reporting requirements for drug manufacturers with respect to drug prices.
Introduced in House • 12/9/2019
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (148)
Party Breakdown
Sponsor
Cosponsors (147)
Bill Journey
Originated in the House
Introduced
December 9, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Related Bills (34)
H.R. 4400
Advancing Education on Biosimilars Act of 2019
H.R. 2700
Lowering Prescription Drug Costs and Extending Community Health Centers and Other Public Health Priorities Act
H.R. 938
BLOCKING Act of 2019
H.R. 965
CREATES Act of 2019
H.R. 1499
Protecting Consumer Access to Generic Drugs Act of 2019
H.R. 1503
Orange Book Transparency Act of 2020
H.R. 1520
Further Extension of Continuing Appropriations Act, 2021
H.R. 2296
More Efficient Tools to Realize Information for Consumers Act
H.R. 2376
Prescription Pricing for the People Act of 2019
H.R. 3443
To clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes.
H.R. 5281
Drug Price Transparency in Medicaid Act of 2019
S. 1227
Prescription Pricing for the People Act of 2019
S. 1636
Ensuring Innovation Act
S. 2740
Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019
H.R. 1264
Payment Commission Data Act of 2019
H.R. 1781
Payment Commission Data Act of 2019
H.R. 1922
Restoring Access to Medication Act of 2019
H.R. 2087
Drug Price Transparency Act
H.R. 2115
Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act
H.R. 3029
Improving Low-Income Access to Prescription Drugs Act of 2019
H.R. 3408
Shop Rx Act of 2019
H.R. 3415
Real-Time Beneficiary Drug Cost Bill
H.R. 5444
Lower Insulin Costs Now Act
S. 801
A bill to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information.
S. 1999
Improving Low Income Access to Prescription Drugs Act of 2019
S. 2051
Strengthening Average Sales Price Reporting Act of 2019
S. 3013
Encouraging Innovative Benefit Design to Lower Costs for Seniors Act
H.R. 5882
GENE Therapy Payment Act
S. 3942
Securing America’s Medical Supply Chain and Advancing the Production of Life Saving Medicines Act
H.R. 6155
To amend the Biologics Price Competition and Innovation Act of 2009 to make improvements with respect to the transition of biological products, and for other purposes.
H.R. 7877
Lowering Drug Costs for Seniors Act of 2020
H.R. 7898
To amend the Health Information Technology for Economic and Clinical Health Act to require the Secretary of Health and Human Services to consider certain recognized security practices of covered entities and business associates when making certain determinations, and for other purposes.
S. 3129
Lower Costs, More Cures Act of 2019
H.R. 4955
Protecting Access to Safe and Effective Medicines Act of 2019